Peculiarities of the clinical course and visceral adipose tissue in patients with non-alcoholic fatty liver disease against the background of metabolic syndrome

Journal Title: Сучасна гастроентерологія - Year 2018, Vol 0, Issue 2

Abstract

Objective — to study the peculiarities of metabolic disturbances in patients with nonalcoholic fatty liver disease (NAFLD) and their role in the development and progression of liver steatosis. Materials and methods. Investigation involved 62 patients with NAFLD: 26 men (40 %) and 36 women (60 %). The mean age of patients was (57.34 ± 9.2) years. The control group consisted of age­ and gender­ matched 20 healthy donors. All patients were undergone physical and instrumental examination in accordance with the current order of the MOH of Ukraine N 826 of 06.11.2014. In addition to the standard survey, the body composition of patients was monitored with the use of OMRON BF­-511 electronic instrument (Japan, 2011), and the visceral adiposity index (VAI) was calculated by the method of Amato MC (2010) to determine visceral adipose tissue dysfunction (VAT). Results. The clinical symptomatology in patients with NAFLD against the background of the metabolic syndrome was defined as a low­symptom type, which did not correlate with the significant changes in the indices of laboratory and instrumental examinations. Among NAFLD patients, the vast majority of patients have had metabolic disorders in the form of type 2 diabetes mellitus (45 %), hypertension (28 %), overweight and obesity (74 %). The VAT rates were elevated in all patients. The VAI parameters in NAFLD patients were higher than in subjects with liver steatosis (p < 0.05). Conclusions. The significant increase in the percentage of visceral adipose tissue and the degree of its activity in patients with NAFLD, regardless of the body mass index, suggested the pathogenetic role of visceral obesity in the development of metabolic changes in this category of patients.

Authors and Affiliations

G. D. Fadieienko, I. E. Kushnir, V. M. Chernova, Т. А. Solomentseva, Ya. V. Nikiforova

Keywords

Related Articles

Sate of intestinal microbiome in patients with osteoarthritis

Objective — to study the composition of intestinal microflora (CM) in patients with osteoarthritis (OA) against the background of administration of non-steroidal anti-inflammatory drugs (NSAIDs) and without them, as well...

The evaluation of specific changes and diagnostic informativeness of the cytokine profile in young patients with gastroesophageal reflux disease, occurring against the background of autoimmune inflammation

Objective — to determine the general trend of changes in the indicators of systemic inflammation — interleukin-1β and interleukin-18, in young patients with gastroesophageal reflux disease (GERD) and autoimmune thyroidit...

The role and place of Actovegin in the complex therapy of cytokine metabolism in patients with GERD with concomitant bronchial asthma

Objective — to study the advisability of the Actovegin inclusion in the standard treatment regimen for patients with GERD and concomitant mild to moderate BA in terms of its effects on the clinical course of this comorbi...

The new opportunities of treatment of non-alcoholic steatohepatitis

Objective — to evaluate the efficacy and safety of the dietary supplement Schisandrin®, 250 mg tablets (manufacturer Pharmacom Ltd.) in patients with non-alcoholic steatohepatitis. Materials and methods. The investigatio...

Peculiarities of microbic landscape at NSAID-induced gastropathy in patients with diabetes mellitus

Objective — to investigate the frequency and nature of microbial lesions of the mucous membrane of the upper gastrointestinal tract in patients with NSAID-induced gastropathy against the background of diabetes mellitus (...

Download PDF file
  • EP ID EP294104
  • DOI -
  • Views 145
  • Downloads 0

How To Cite

G. D. Fadieienko, I. E. Kushnir, V. M. Chernova, Т. А. Solomentseva, Ya. V. Nikiforova (2018). Peculiarities of the clinical course and visceral adipose tissue in patients with non-alcoholic fatty liver disease against the background of metabolic syndrome. Сучасна гастроентерологія, 0(2), 10-15. https://europub.co.uk/articles/-A-294104